Skip to Main

Publications

  1. Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study. Ulndreaj A, Brinc D, Altan M, Pons-Belda OD, Fernandez-Uriarte A, Mu-Mosley H, Fattah F, von Itzstein MS, Soosaipillai A, Kulasingam V, Palaskas NL, Gerber DE, Diamandis EP, Heymach JV, Prassas I. Clin Chem Lab Med. 2022 Oct 27;61(1):154-161. PMID: 36287134
  2. Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors. von Itzstein MS, Gonugunta AS, Wang Y, Sheffield T, Lu R, Ali S, Fattah FJ, Xie D, Cai J, Xie Y, Gerber DE. Cancer Immunol Immunother. 2022 Sep;71(9):2169-2181. PMID: 35072744
  3. Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus. Freifeld Y, Pedrosa I, Mclaughlin M, Correa RM, Louie AV, Maldonado JA, Tang C, Kadow B, Kutikov A, Uzzo RG, Porta C, Bucknell NW, Siva S, Brugarolas J, Margulis V, Timmerman R, Hannan R. Urol Oncol. 2022 Apr;40(4):166.e9-166.e13. PMID: 35144866
  4. Humoral and cellular correlates of a novel immune-related adverse event and its treatment. Gonugunta AS, von Itzstein MS, Mu-Mosley H, Fattah F, Farrar JD, Mobely A, Rashdan S, Lai S, Bhai SF, Bermas BL, Karp D, Li QZ, Wakeland EK, Gerber DE. J Immunother Cancer. 2021 Dec;9(12):e003585. PMID: 34880115
  5. Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients. Welder D, Jeon-Slaughter H, Ashraf B, Choi SH, Chen W, Ibrahim I, Bat T. Br J Haematol. 2021 Aug;194(3):530-536. PMID: 34132393
  6. Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors. Ahmed M, von Itzstein MS, Sheffield T, Khan S, Fattah F, Park JY, Popat V, Saltarski JM, Gloria-McCutchen Y, Hsiehchen D, Ostmeyer J, Khan SA, Sultana N, Xie Y, Li QZ, Wakeland EK, Gerber DE. J Immunother Cancer. 2021 Jun;9(6):e002349. PMID: 34127546
  7. Drug exposure: still relevant after all these years. Gerber DE, Putnam WC. Oncotarget. 2021 Apr 13;12(8):721-722. PMID: 33889295
  8. Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis. Balachandra S, Kusin SB, Lee R, Blackwell JM, Tiro JA, Cowell LG, Chiang CM, Wu SY, Varma S, Rivera EL, Mayo HG, Ding L, Sumer BD, Lea JS, Bagrodia A, Farkas LM, Wang R, Fakhry C, Dahlstrom KR, Sturgis EM, Day AT. Cancer. 2021 Mar 15;127(6):850-864. PMID: 33270909
  9. Experimental and numerical studies on kV scattered x-ray imaging for real-time image guidance in radiation therapy. Huang Y, Yang K, Lai Y, Liu H, Shen C, Zhong Y, Shao Y, Li X, Liu B, Jia X. Phys Med Biol. 2021 Feb 11;66(4):045022. PMID: 33361559
  10. FPGA-based distributed coincidence processor for high count-rate online PET coincidence data acquisition. Cheng X, Hu K, Yang D, Shao Y. Phys Med Biol. 2021 Jan 21. PMID: 33477130
  11. The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement. Bergstrom CP, Dahiya S, Chen W, Zhang CC, Zhu H, Yan J, Madanat Y, Patel P, Vusirkala M, Ramakrishnan P, Rizvi S, Chung S, Awan F, Anderson LD Jr, Collins R, Kansagra A. Leuk Res. 2021 Jan;100:106480. PMID: 33285315
  12. Omega-3 fatty acid intake suppresses induction of diverse autoantibody repertoire by crystalline silica in lupus-prone mice. Rajasinghe LD, Li QZ, Zhu C, Yan M, Chauhan PS, Wierenga KA, Bates MA, Harkema JR, Benninghoff AD, Pestka JJ. Autoimmunity. 2020 Nov;53(7):415-433. PMID: 32903098
  13. Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer. Gerber DE, Putnam WC, Fattah FJ, Kernstine KH, Brekken RA, Pedrosa I, Skelton R, Saltarski JM, Lenkinski RE, Leff RD, Ahn C, Padmanabhan C, Chembukar V, Kasiri S, Kallem RR, Subramaniyan I, Yuan Q, Do QN, Xi Y, Reznik SI, Pelosof L, Faubert B, DeBerardinis RJ, Kim J. Clin Cancer Res. 2020 Nov 15;26(22):6017-6027. PMID: 32847935
  14. Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma. Cheng CC, Wooten J, Gibbs ZA, McGlynn K, Mishra P, Whitehurst AW. Elife. 2020 Sep 29;9:e58108. PMID: 32990599
  15. PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma. Chen H, Molberg K, Strickland AL, Castrillon DH, Carrick K, Jiang Q, Niu S, Rivera-Colon G, Gwin K, Hinson S, Lea J, Miller DS, Zheng W, Lucas E. Am J Surg Pathol. 2020 Aug;44(8):1050-1060. PMID: 32384321
  16. Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A "Two-Hit" Autoimmune Toxicity or Clinical Predisposition? von Itzstein MS, Khan S, Popat V, Lu R, Khan SA, Fattah FJ, Park JY, Bermas BL, Karp DR, Ahmed M, Saltarski JM, Gloria-McCutchen Y, Xie Y, Li QZ, Wakeland EK, Gerber DE. Oncologist. 2020 Aug;25(8):e1242-e1245. PMID: 32400023
  17. Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor-Induced Raynaud's-Like Phenomenon. Khan S, von Itzstein MS, Lu R, Bermas BL, Karp DR, Khan SA, Fattah FJ, Park JY, Saltarski JM, Gloria-McCutchen Y, Xie Y, Li QZ, Wakeland EK, Gerber DE. Oncologist. 2020 May;25(5):e753-e757. PMID: 32167195
  18. EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer. Gong K, Guo G, Panchani N, Bender ME, Gerber DE, Minna JD, Fattah F, Gao B, Peyton M, Kernstine K, Mukherjee B, Burma S, Chiang CM, Zhang S, Sathe AA, Xing C, Dao KH, Zhao D, Akbay EA, Habib AA. Nat Cancer. 2020 Apr;1(4):394-409. PMID: 33269343
  19. DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors. Chung JS, Ramani V, Kobayashi M, Fattah F, Popat V, Zhang S, Cruz PD Jr, Gerber DE, Ariizumi K. Clin Cancer Res. 2020 Mar 15;26(6):1449-1459. PMID: 31822499
  20. Novel On-line PET Imaging for Intra-Beam Range Verification and Delivery Optimization: A Simulation Feasibility Study. Zhong Y, Lu W, Chen M, Xiong Z, Cheng X, Hu K, Shao Y. IEEE Trans Radiat Plasma Med Sci. 2020 Mar;4(2):212-217. PMID: 33778233
  21. Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells. Pouzolles M, Machado A, Guilbaud M, Irla M, Gailhac S, Barennes P, Cesana D, Calabria A, Benedicenti F, Sergé A, Raman I, Li QZ, Montini E, Klatzmann D, Adjali O, Taylor N, Zimmermann VS. J Allergy Clin Immunol. 2020 Feb;145(2):679-697.e5. PMID: 31513879
  22. A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients. Ogunrinde E, Zhou Z, Luo Z, Alekseyenko A, Li QZ, Macedo D, Kamen DL, Oates JC, Gilkeson GS, Jiang W. Arthritis Rheumatol. 2019 Nov;71(11):1858-1868. PMID: 31106972
  23. Immune dysregulation in cancer patients developing immune-related adverse events. Khan S, Khan SA, Luo X, Fattah FJ, Saltarski J, Gloria-McCutchen Y, Lu R, Xie Y, Li Q, Wakeland E, Gerber DE. Br J Cancer. 2019 Jan;120(1):63-68. PMID: 30377338
  24. Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis. Gerber DE, Beg MS, Fattah F, Frankel AE, Fatunde O, Arriaga Y, Dowell JE, Bisen A, Leff RD, Meek CC, Putnam WC, Kallem RR, Subramaniyan I, Dong Y, Bolluyt J, Sarode V, Luo X, Xie Y, Schwartz B, Boothman DA. Br J Cancer. 2018 Oct;119(8):928-936. PMID: 30318513
  25. Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly (ADP-ribose) Polymerase Inhibitors. Huang X, Motea EA, Moore ZR, Yao J, Dong Y, Chakrabarti G, Kilgore JA, Silvers MA, Patidar PL, Cholka A, Fattah F, Cha Y, Anderson GG, Kusko R, Peyton M, Yan J, Xie XJ, Sarode V, Williams NS, Minna JD, Beg M, Gerber DE, Bey EA, Boothman DA. Cancer Cell. 2016 Dec 12;30(6):940-952. PMID: 27960087
  26. Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer. Gerber DE, Boothman DA, Fattah FJ, Dong Y, Zhu H, Skelton RA, Priddy LL, Vo P, Dowell JE, Sarode V, Leff R, Meek C, Xie Y, Schiller JH. Lung Cancer. 2015 Dec;90(3):534-41. PMID: 26474959
Back-to top